APA (7th ed.) Citation

Katayama, T., Sawada, J., Kikuchi-Takeguchi, S., Kano, K., Takahashi, K., Saito, T., . . . Hasebe, N. (2020). Cerebrospinal fluid levels of alpha-synuclein, amyloid β, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson’s disease, dementia with Lewy bodies or other neurological disorders: Their relationships with cognition and nuclear medicine imaging findings. Neuroscience letters, 715, 134564. https://doi.org/10.1016/j.neulet.2019.134564

Chicago Style (17th ed.) Citation

Katayama, Takayuki, Jun Sawada, Shiori Kikuchi-Takeguchi, Kohei Kano, Kae Takahashi, Tsukasa Saito, Atsutaka Okizaki, and Naoyuki Hasebe. "Cerebrospinal Fluid Levels of Alpha-synuclein, Amyloid β, Tau, Phosphorylated Tau, and Neuron-specific Enolase in Patients with Parkinson’s Disease, Dementia with Lewy Bodies or Other Neurological Disorders: Their Relationships with Cognition and Nuclear Medicine Imaging Findings." Neuroscience Letters 715 (2020): 134564. https://doi.org/10.1016/j.neulet.2019.134564.

MLA (9th ed.) Citation

Katayama, Takayuki, et al. "Cerebrospinal Fluid Levels of Alpha-synuclein, Amyloid β, Tau, Phosphorylated Tau, and Neuron-specific Enolase in Patients with Parkinson’s Disease, Dementia with Lewy Bodies or Other Neurological Disorders: Their Relationships with Cognition and Nuclear Medicine Imaging Findings." Neuroscience Letters, vol. 715, 2020, p. 134564, https://doi.org/10.1016/j.neulet.2019.134564.